First human trial of Oxford Covid-19 vaccine shows promise
Monday, 20 July 2020 ()
London - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year. The vaccine, called AZD1222, has been described by the World Health Organization's chief scientist as the leading candidate in a global race to halt a pandemic that has...
You Might Like
💡 One News Page Knowledge: Other News Mentions
London's mayor proposes key workers get priority for cheaper housingSadiq Khan launches a consultation asking which occupations could be prioritised for cheaper homes.
‘Don’t we owe these children a duty of care?’The London grandmother who wants her grandchildren to return from Kurdish-run camps in Syria.
Woman claims she saw Prince Andrew with Ghislaine Maxwell and Virginia Giuffre on 'Woking Pizza Express' nightShe alleges she saw them at London nightclub Tramp, US lawyer says
Alexander Kareem death: Seven arrested in case of 'mistaken identity' murderSeven people have been arrested on suspicion of the murder of Alexander Kareem, who was shot dead in Shepherd's Bush in west London in a suspected case of..
Drag queen embraces disability
Credit: PA - Press Association STUDIO Duration: 01:00Published
Europe Inc. plunges into the red
Credit: Reuters Studio Duration: 01:37Published
DBT readies five sites for final phase of human trials of Oxford Covid vaccine: SecretaryFive sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca Covid-19 vaccine, Department of Biotechnology..
Sanofi eyes vaccine approval by early 2021
Credit: Reuters Studio Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead
Credit: Reuters Studio Duration: 01:09Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Credit: ANI Duration: 02:24Published
Serum gets DCGI nod for Phase 2 & 3 trialsIndia’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford..
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again
Credit: ANI Duration: 01:38Published
DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccineThe Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford..
Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidateA subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for..
Coronavirus did come from bats, say WHO scientists sent to WuhanThe coronavirus outbreak came from bats and was probably passed to humans through another intermediary animal "host", World Health Organisation (WHO) scientists..
WHO Warns There May Never Be A 'Silver Bullet' for COVID-19
Credit: Cover Video STUDIO Duration: 00:55Published
6 months after declaring the coronavirus a global health emergency, WHO director says there may ...Fabrice Coffrini / AFP / Getty World Health Organization's director-general on Monday warned that there may never be a "silver bullet" for the coronavirus...
Related videos from verified sources
Related news from verified sources
Tweets about this